trending Market Intelligence /marketintelligence/en/news-insights/trending/npyszm61yeam2azrun5cnq2 content esgSubNav
In This List

Thermo Fisher board approves $2B share repurchase program

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


Thermo Fisher board approves $2B share repurchase program

Thermo Fisher Scientific Inc. said its board authorized the repurchase of $2 billion of its common shares.

The Waltham, Mass.-based life sciences company still has the authorization to repurchase $250 million worth of stock from its last cohort announced in July 2016 for a total of $1.5 billion.

Thermo Fisher Scientific said this authorization comes without an expiration date. The company will buy from the open market and directly from the sellers.